How Will the Food and Drug Administration Regulate Generative AI–Enabled Medical Devices?
Journal of Medical Internet Research · 02.11.2026 · 28 · e115030-e115030
DOI: 10.2196/115030 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Internet Research, online erschienen am 02.11.2026. Verfasst von Simon Spichak. Hauptthemen laut MEDLINE: United States Food and Drug Administration, Artificial Intelligence, Device Approval, Equipment and Supplies. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
As the US Food and Drug Administration works to develop specific guidelines for the regulation of AI-enabled medical devices, could a previously cleared tool provide some clues as to what the new guidance will look like? In this News and Perspectives article, JMIR Correspondent Simon Spichak reports on and speaks with experts about the UpDoc diabetes management app and the future of AI regulation as AI-enabled devices continue to evolve.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Zitieren
APA
Spichak, S. (2026). How Will the Food and Drug Administration Regulate Generative AI–Enabled Medical Devices?. Journal of Medical Internet Research, 28, e115030-e115030. https://doi.org/10.2196/115030
Vancouver
Spichak S. How Will the Food and Drug Administration Regulate Generative AI–Enabled Medical Devices?. Journal of Medical Internet Research. 2026;28:e115030-e115030. doi:10.2196/115030
BibTeX
@article{Spichak2026,
author = {Spichak, Simon},
title = {How Will the Food and Drug Administration Regulate Generative AI–Enabled Medical Devices?},
journal = {Journal of Medical Internet Research},
year = {2026},
volume = {28},
pages = {e115030--e115030},
doi = {10.2196/115030}
}
EUVIMED